Over the past two decades, the Leishmaniasis East Africa Platform (LEAP) has made significant progress in fighting leishmaniasis in Eastern Africa, which currently has the highest number of visceral leishmaniasis (VL) cases world-wide. LEAP and DNDi have been collaborating to develop and introduce better treatments for leishmaniasis. LEAP's success is a testament to the power of collaboration. The platform brings together researchers, clinicians, healthcare workers, and community members to fight leishmaniasis.